학술논문
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
Document Type
Article
Author
Ljungman, Per; Bermudez, Arancha; Logan, Aaron C.; Kharfan-Dabaja, Mohamed A.; Chevallier, Patrice; Martino, Rodrigo; Wulf, Gerald; Selleslag, Dominik; Kakihana, Kazuhiko; Langston, Amelia; Lee, Dong-Gun; Solano, Carlos; Okamoto, Shinichiro; Smith, Larry R.; Boeckh, Michael; Wingard, John R.; Cywin, Beth; Fredericks, Christine; Lademacher, Christopher; Wang, Xuegong; Young, James; Maertens, Johan
Source
In EClinicalMedicine March 2021 33
Subject
Language
ISSN
2589-5370